NRG1 and amyotrophic lateral sclerosis: While viral-mediated delivery of NRG1-III into the spinal cord of ALS mice restored C-bouton numbers and increased survival [29,30], intraventricular administration of NRG1 showed no therapeutic benefit whereas neuroprotective effects have been reported following blockade of endogenous NRG1 signaling [31].